HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem R&D

This article was originally published in The Rose Sheet

Executive Summary

Firm completes construction of its $2 mil., 10,000-sq.-ft. research and development facility in Chattanooga, Tenn. mid-November, about three weeks ahead of schedule. Chattem has significantly increased focus on R&D over the past two years. The consumer products manufacturer is set to launch multiple new items over the next few months including BullFrog Mosquito Coast, which combines sunscreen with insect repellent and is designed to last six to eight hours. Chattem also reports Icy Hot pain-relieving patch product sales are "doing well" in the fourth quarter despite Pfizer's recent introduction of BenGay Pain Relieving Patch and continued competition from Procter & Gamble's ThermaCare line of pain-relief wraps...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011726

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel